# A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

> **NCT02915809** · PHASE3 · UNKNOWN · sponsor: **Green Cross Corporation** · enrollment: 414 (estimated)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** GC3110B vaccine
- **BIOLOGICAL:** GCFLU Quadrivalent Inj. vaccine

## Key facts

- **NCT ID:** NCT02915809
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-05
- **Target enrollment:** 414 (ESTIMATED)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02915809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02915809, "A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02915809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*